40046-28-4 Usage
Uses
Used in Pharmaceutical Industry:
4-Methoxy-2-methylphenyl isothiocyanate is used as a key intermediate for the synthesis of various organic compounds with potential medicinal properties. Its unique chemical structure allows it to be a valuable building block in the development of new pharmaceuticals.
Used in Organic Synthesis:
In the field of organic synthesis, 4-Methoxy-2-methylphenyl isothiocyanate is used as a reagent and building block. Its versatility in chemical reactions makes it a valuable component in the creation of a wide range of organic compounds for various applications.
Used in Chemical Reactions:
4-Methoxy-2-methylphenyl isothiocyanate is utilized in various chemical reactions due to its reactivity and ability to form different types of chemical bonds. This property makes it a useful compound in the synthesis of complex organic molecules and the development of new chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 40046-28-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,0,4 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 40046-28:
(7*4)+(6*0)+(5*0)+(4*4)+(3*6)+(2*2)+(1*8)=74
74 % 10 = 4
So 40046-28-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NOS/c1-7-5-8(11-2)3-4-9(7)10-6-12/h3-5H,1-2H3
40046-28-4Relevant academic research and scientific papers
THIAZOLE AND PYRAZOLE DERIVATIVES AS FLT-3 KINASE INHIBITORS
-
Page/Page column 42, (2010/02/11)
The invention relates to thiazole and pyrazole derivatives of formula (I) wherein Q is S and X is C, or Q is CH and X is N; R1 is unsubtituted or substituted phenyl; and R2 is unsubstituted or substituted aryl or heteroaryl; oa a salt of the said compounds, and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour disease, in particular such diseases which respond to an inhibition of the FIt-3 kinase.
